RET-IN-15
Product Specifications
UNSPSC Description
RET-IN-15 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021115457A1 compound 51. RET-IN-15 can be used for the research of cancer[1].
Target Antigen
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ret-in-15.html
Solubility
10 mM in DMSO
Smiles
N#CC1=C2C(C3=CC=C(N4CC(C5)N(CC6=CC=C(OC)N=C6)C5C4)N=C3)=CC(NCCO)=CN2N=C1
Molecular Weight
496.56
References & Citations
[1]Chen HM, et, al. Pyrazolo[1,5-a]pyridine compound, preparation method therefor and use thereof. WO2021115457A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-144422/RET-IN-15-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-144422/
Clinical Information
No Development Reported
CAS Number
2643375-86-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
